Commercial Bone Grafts Claimed as an Alternative to Autografts: Current Trends for Clinical Applications in Orthopaedics
Marco Govoni,Leonardo Vivarelli,Alessandro Mazzotta,Cesare Stagni,Alessandra Maso,Dante Dallari +5 more
Reads0
Chats0
TLDR
In this paper, a review of the global bone augmentation materials mimicking autografts is presented, which can be classified into three main categories: cellular bone matrices, growth factor enhanced bone grafts, and peptide enhanced xeno-hybrid bone graft.Abstract:
In the last twenty years, due to an increasing medical and market demand for orthopaedic implants, several grafting options have been developed. However, when alternative bone augmentation materials mimicking autografts are searched on the market, commercially available products may be grouped into three main categories: cellular bone matrices, growth factor enhanced bone grafts, and peptide enhanced xeno-hybrid bone grafts. Firstly, to obtain data for this review, the search engines Google and Bing were employed to acquire information from reports or website portfolios of important competitors in the global bone graft market. Secondly, bibliographic databases such as Medline/PubMed, Web of Science, and Scopus were also employed to analyse data from preclinical/clinical studies performed to evaluate the safety and efficacy of each product released on the market. Here, we discuss several products in terms of osteogenic/osteoinductive/osteoconductive properties, safety, efficacy, and side effects, as well as regulatory issues and costs. Although both positive and negative results were reported in clinical applications for each class of products, to date, peptide enhanced xeno-hybrid bone grafts may represent the best choice in terms of risk/benefit ratio. Nevertheless, more prospective and controlled studies are needed before approval for routine clinical use.read more
Citations
More filters
Journal ArticleDOI
Calcium Phosphate-Based Biomaterials for Bone Repair
Xiao-Dong Hou,Lei Zhang,Zifei Zhou,Xiong Luo,Tian-Long Wang,Xin-Yu Zhao,Bing-Qiang Lu,Feng Chen,Longpo Zheng +8 more
TL;DR: This review focuses on the relationships and interactions between the physicochemical/biological properties of CaP biomaterials and their species, sizes, and morphologies in bone regeneration, including synthesis strategies, structure control, biological behavior, and the mechanisms ofCaP in promoting osteogenesis.
Journal ArticleDOI
The Role of Growth Factors in Bioactive Coatings.
Dragana Bjelić,Matjaž Finšgar +1 more
TL;DR: The incorporation of growth factors in a bioactive coating represents a novel approach in bone tissue engineering, in which osteoinduction is enhanced in order to create the optimal conditions for the bone healing process, which crucially affects implant fixation as discussed by the authors.
Journal ArticleDOI
Bioengineered Living Bone Grafts—A Concise Review on Bioreactors and Production Techniques In Vitro
TL;DR: The review article describes the types of biomaterials and sources of cells that can be used in BTE as well as the role of three-dimensional bioprinting and pulsed electromagnetic fields in both bone healing and BTE.
Journal ArticleDOI
Nanotopographical 3D-Printed Poly(ε-caprolactone) Scaffolds Enhance Proliferation and Osteogenic Differentiation of Urine-Derived Stem Cells for Bone Regeneration
TL;DR: It is demonstrated that nanotopographical 3D-printed scaffolds loaded with urine-derived stem cells (USCs) are a safe and effective therapeutic strategy for bone regeneration.
Journal ArticleDOI
Bioresorbable Chitosan-Based Bone Regeneration Scaffold Using Various Bioceramics and the Alteration of Photoinitiator Concentration in an Extended UV Photocrosslinking Reaction
Farah Alwani Azaman,Keran Zhou,Mar Blanes-Martínez,Margaret Brennan Fournet,Declan M. Devine +4 more
TL;DR: In this paper , a chitosan (CS) scaffold with combinations of bioactive ceramics, namely hydroxyapatite (HAp), tricalcium phosphate-α (TCP-α), and fluorapatitic (FAp), with a fixed concentration of benzophenone photoinitiator (50 µL of 0.1% (w/v)) and crosslinked using a UV curing system.
References
More filters
Journal ArticleDOI
Mesenchymal and haematopoietic stem cells form a unique bone marrow niche
Simón Méndez-Ferrer,Tatyana V. Michurina,Francesca Ferraro,Amin R. Mazloom,Ben D. MacArthur,Ben D. MacArthur,Sergio A. Lira,David T. Scadden,Avi Ma'ayan,Grigori Enikolopov,Paul S. Frenette,Paul S. Frenette +11 more
TL;DR: It is demonstrated that mesenchymal stem cells (MSCs), identified using nestin expression, constitute an essential HSC niche component and are indicative of a unique niche in the bone marrow made of heterotypic stem-cell pairs.
Journal ArticleDOI
Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures a prospective, controlled, randomized study of four hundred and fifty patients
TL;DR: The rhBMP-2 implant was safe and, when 1.50 mg/mL was used, significantly superior to the standard of care in reducing the frequency of secondary interventions and the overall invasiveness of the procedures, accelerating fracture and wound-healing, and reducing the infection rate in patients with an open fracture of the tibia.
Journal ArticleDOI
Bone grafts and biomaterials substitutes for bone defect repair: A review.
Wenhao Wang,Kelvin W.K. Yeung +1 more
TL;DR: The currently available bone grafts and bone substitutes as well as the biological and bio-inorganic factors for the treatments of bone defect are reviewed.
Journal ArticleDOI
Mesenchymal stem cells: immune evasive, not immune privileged
TL;DR: Protecting MSCs from immune detection and prolonging their persistence in vivo may improve clinical outcomes and prevent patient sensitization toward donor antigens.
Journal ArticleDOI
Fracture healing: mechanisms and interventions
TL;DR: The developmental progression of fracture healing at the tissue, cellular and molecular levels is reviewed and strategies for fracture treatment that have been tested in animal models and in clinical trials or case series are presented.
Related Papers (5)
Bone grafts and biomaterials substitutes for bone defect repair: A review.
Wenhao Wang,Kelvin W.K. Yeung +1 more